Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Factors to Consider in Development of Drugs for Pediatric Nonalcoholic Fatty Liver Disease
Miriam B. Vos, Lara Dimick‐Santos, Ruby Mehta, et al.
Gastroenterology (2019) Vol. 157, Iss. 6, pp. 1448-1456.e1
Open Access | Times Cited: 12

Showing 12 citing articles:

Advancing the global public health agenda for NAFLD: a consensus statement
Jeffrey V. Lazarus, Henry E. Mark, Quentin M. Anstee, et al.
Nature Reviews Gastroenterology & Hepatology (2021) Vol. 19, Iss. 1, pp. 60-78
Open Access | Times Cited: 522
Nonalcoholic Fatty Liver Disease in Children: Unique Considerations and Challenges
Dana Goldner, Joel E. Lavine
Gastroenterology (2020) Vol. 158, Iss. 7, pp. 1967-1983.e1
Closed Access | Times Cited: 98
Progression of Fatty Liver Disease in Children Receiving Standard of Care Lifestyle Advice
Stavra A. Xanthakos, Joel E. Lavine, Katherine P. Yates, et al.
Gastroenterology (2020) Vol. 159, Iss. 5, pp. 1731-1751.e10
Open Access | Times Cited: 70
Perspectives on youth‐onset nonalcoholic fatty liver disease
Eduardo Castillo‐Leon, Catherine E. Cioffi, Miriam B. Vos
Endocrinology Diabetes & Metabolism (2020) Vol. 3, Iss. 4
Open Access | Times Cited: 40
Randomized placebo‐controlled trial of losartan for pediatric NAFLD
Miriam B. Vos, Mark L. Van Natta, Niviann Blondet, et al.
Hepatology (2022) Vol. 76, Iss. 2, pp. 429-444
Open Access | Times Cited: 25
A proposal from the liver forum for the management of comorbidities in non-alcoholic steatohepatitis therapeutic trials
Raluca Pais, Bertrand Cariou, Mazen Noureddin, et al.
Journal of Hepatology (2023) Vol. 79, Iss. 3, pp. 829-841
Closed Access | Times Cited: 10
Recent advances in understanding and managing pediatric nonalcoholic fatty liver disease
Jennifer Vittorio, Joel E. Lavine
F1000Research (2020) Vol. 9, pp. 377-377
Open Access | Times Cited: 25
An Open Label, Randomized, Multicenter Study of Elafibranor in Children With Nonalcoholic Steatohepatitis
Nidhi Goyal, Ali Mencin, Kimberly P. Newton, et al.
Journal of Pediatric Gastroenterology and Nutrition (2023) Vol. 77, Iss. 2, pp. 160-165
Closed Access | Times Cited: 8
Attribution of Nonalcoholic Steatohepatitis as an Etiology of Cirrhosis for Clinical Trials Eligibility: Recommendations From the Multi-stakeholder Liver Forum
Mazen Noureddin, Jean L. Chan, Katherine Barradas, et al.
Gastroenterology (2020) Vol. 159, Iss. 2, pp. 422-427.e1
Open Access | Times Cited: 17
Diagnostic and Treatment Dilemmas in Pediatric NAFLD
Bryan Rudolph
Clinical Liver Disease (2021) Vol. 18, Iss. 1, pp. 37-39
Open Access | Times Cited: 2
Burden of non-alcoholic steatohepatitis among children with type 2 diabetes mellitus
Lauren E. Parlett, Qinli Ma, Qian Shi, et al.
Diabetology & Metabolic Syndrome (2021) Vol. 13, Iss. 1
Open Access | Times Cited: 1
IMPORTÂNCIA DA BIÓPSIA NO DIAGNÓSTICO DA DOENÇA HEPÁTICA GORDUROSA NÃO ALCOÓLICA EM PEDIATRIA
MARCELO BALI DE AGUIAR MOREIRA, NÁTHALY NASCIMENTO DE ABREU, GABRIELA MARTINS FAVARETTI, et al.
Editora Pasteur eBooks (2022), pp. 73-85
Open Access
Page 1

Scroll to top